SIG: Cell and Gene Therapy

All,

We hope this message finds you well.

We are writing to inform you about an upcoming leadership transition within our SIG.  We will be transitioning out of our roles as chair and vice chair effective on August 15, 2024. It has been an honor and privilege to serve the SIG over the past two years.  We want to take this opportunity to thank you all for your dedication and contributions to SIG's success. 

We are pleased to announce that Jamie Geier and Lourens Bloem will be stepping into the role of chair and vice chair respectively.  Jamie and Lourens have been a valuable member of the SIG for two years and have demonstrated strong leadership qualities and a deep commitment to the SIG's goals and mission.  We are confident they will excel in these new roles and continue to lead the SIG towards success.   Please join us in congratulating Jamie and Lourens!

We are also looking for a secretary role in the SIG.  Please feel free to reach out to us if you are interested.  Thank you for your continued support and commitment.

Kind regards,

Quazi and Kui